Notes
Slide Show
Outline
1
Community-Based Interventions to Tackle Poverty-Associated Diseases:
Case Study of Trachoma
  • Jacob Kumaresan
  • President, International Trachoma Initiative


2
Communicable Diseases: Burden
  • 60% Deaths Communicable diseases
  • 64% DALYs
  • Deaths Cases
  • TB 2 - 3 million 8 million
  • HIV/AIDS 3 million 40 million (prevalence)
  • Malaria 1 million 300 – 500 million



  • 25% of DALYs Infectious/ Parasitic diseases
  • (neglected)






3
Selected Parasitic and Infectious Diseases in Africa
  • Disease Target Population
  • Lymphatic filariasis 300 million
  • Schistosomiasis 200 million
  • Intestinal Helminths 400 million


  • Onchocerciasis 80 million
  • Trachoma 168 million




4
Health Partnerships Supported by Pharma
  • HIV/AIDS: 18
    • Accelerating Access Initiative (AAI)
    • Diflucan® Partnership Program
    • International AIDS Vaccine Initiative (IAVI)
  • Malaria: 12
    • GSK African Malaria Partnership
    • Medicines for Malaria Venture (MMV)
    • Novartis Coartem®
  • Tuberculosis: 8
    • Global Alliance for TB Drug Development (TB Alliance)
    • Lilly MDR-TB Partnership
    • Novartis TB DOTS Donation
  • Tropical Diseases: 8
    • Global Alliance to Eliminate Leprosy (GAEL)
    • International Trachoma Initiative (ITI)
    • Merck MECTIZAN® Donation Program (MDP)
  • Vaccine Preventable Diseases: 6
    • Global Alliance for Vaccines and Immunization (GAVI)
    • Global Polio Eradication Initiative



5
Major Accomplishments by Disease Tropical Diseases
  • Global Alliance to Eliminate Leprosy
  • Currently over 13 million people have been cured of Leprosy, 2.5 million treated with Novartis donation and since 1985, the prevalence rate has dropped by over 90%
  • Global Alliance to Eliminate Lymphatic Filariasis
  • Since 2003, 100 million treatments donated in 34 countries and over 80 million people protected against Lymphatic Filariasis
  • Guinea Worm Eradication Program
  • Since 1986, the disease burden of Guinea Worm has been reduced by 99%
  • Merck MDP
  • Since 1987 over 300 million treatments have been administered for Onchocerciasis
6
Trachoma is the world’s leading cause of preventable blindness
  • Trachoma - a disease associated with poverty
    •  7.6 million visually impaired
    •  84 million with active infection
    •  $2.9 billion in productivity losses/year


  • Trachoma – disproportionately affects mothers and children
    •  Prevalence of infection highest in 1 to 5 year olds
    •  Women blinded up to 3 times more than men


7
Knowledge of Burden:
Active Trachoma
  • Total number of active cases: 84 million
    •  China: 26 million
    •  India: 20 million
    •  Ethiopia: 9 million
    •  Sudan, Egypt: 3 million
    •  Tanzania, Kenya, Yemen, Niger: 2 million
    •  Cambodia, Mali, Burkina, Brazil, Chad, Uganda: 1 million
8
 
9
Repeated infections lead to blindness
10
 
11
 
12
 
13
 
14
History of Trachoma
  • Known to the Egyptians as well as Hippocrates


  • Copper Sulfate


  • First noted in Europe as a result of French occupation in Egypt


  • Last UK trachoma unit closed in 1947; US trachoma hospitals in 1950s
15
Preventing the Spread of Trachoma in the US
16
Free traveling trachoma clinic
17
 
18
 
19
Milestones
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
SAFE in Action - Morocco

Evaluation Results:  Morocco Active disease in children reduced by over 90%
28
"International Trachoma Initiative"
  • International Trachoma Initiative
  • “Dedicated to the elimination of blinding trachoma, the world’s leading cause of preventable blindness.”
29
ITI-Supported National Programs
30
ITI-Supported National Programs
 1998 - 2004
31
Zithromax Distribution: NIGER
32
Rapid program expansion in Niger
33
From Pilot Projects to 5 Year National Plans
  • In 2004, ITI supported the development of national plans by the Ministries of Health and partners in:


    • Ethiopia
    • Ghana
    • Mali
    • Nepal
    • Niger
    • Tanzania
    • Vietnam




34
 
35
 
36
 
37
Zithromax Distribution: MALI
38
Ethiopia: Pit Latrine Promotion Project
Current Wat-San Situation
  • Sanitation coverage in rural communities of the Amhara region is <4%
  • Safe water coverage in the same rural communities is <25%
  • Very low awareness on hygiene and sanitation


39
 
40
Latrines: A Gender Issue
  • Local traditions do not allow women to defecate during the day (in the Amhara region)
    • Women had to relieve themselves early in the morning or late in the evening (hiding themselves)
  • Women activists (promoters) used this obsolete tradition to mobilize women
  • Women, being more affected than men with trachoma, fueled the need to dig and use latrine as urgently as possible


41
 
42
The Outcome

  • Annual 2004 target:  5,000 pit latrines
  • Following training, motivation and community mobilization:
  • Total # of pit latrines constructed:  89,000


43
Reasons for Success
  • CONVICTION: In order to change others, we may have to change ourselves first
  • VISION: Leaders
  • COMMITMENT: At all levels
  • THINK BIG, START SMALL, ACT NOW!
44
What will it take to eliminate blinding trachoma?
  •  Government commitment and ownership in trachoma endemic countries
  •  Strengthening of partnerships
  • Community engagement and empowerment
45